Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P33
Within normal range
vs 2Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-34.67%
2024-119.37%
202348.74%
2022-12.31%
2021-191.57%
20200.00%
20190.00%